Pharmacogenetic-guided algorithms to estimate personalized dose or individual responses to anti-thrombotic drugs
Conclusions In addition to genotyping data, inter-individual variation in non-genetic factors, such as clinical laboratory data, should be considered to predict drug response more accurately in each individual.
Source: Personalized Medicine Universe - Category: Drugs & Pharmacology Source Type: research
More News: Angioplasty | Aspirin | Cardiology | Cardiovascular | Clopidogrel | Coronary Angioplasty | Coumadin | Drugs & Pharmacology | Genetics | Heart | Laboratory Medicine | Percutaneous Coronary Intervention | Plavix | Study | Warfarin